|
| 37925055 | Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization. | Mod Pathol | 2024 |
| 37883178 | Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. | J Clin Invest | 2024 |
| 36007103 | High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. | Clin Cancer Res | 2023 |
| 37558129 | HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. | Mod Pathol | 2023 |
| 37905095 | Chronic Interferon Stimulated Gene Transcription Promotes Oncogene Induced Breast Cancer. | bioRxiv | 2023 |
| 37591896 | Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. | Nat Commun | 2023 |
| 37853138 | Large language models should be used as scientific reasoning engines, not knowledge databases. | Nat Med | 2023 |
| 37795442 | ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy. | Front Oncol | 2023 |
| 37587346 | Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. | Nature | 2023 |
| 37945902 | Most large structural variants in cancer genomes can be detected without long reads. | Nat Genet | 2023 |
| 37612508 | Non-cell-autonomous cancer progression from chromosomal instability. | Nature | 2023 |
| 37608772 | Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer | J Pathol | 2023 |
| 37608771 | Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. | J Pathol | 2023 |
| 37607324 | Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma. | J Clin Oncol | 2023 |
| 37353557 | Rare subtypes of triple negative breast cancer: Current understanding and future directions. | NPJ Breast Cancer | 2023 |
| 37024522 | Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology. | NPJ Breast Cancer | 2023 |
| 37087482 | Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge. | NPJ Precis Oncol | 2023 |
| 36945540 | Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study. | medRxiv | 2023 |
| 37179225 | Metaplastic Breast Cancer: Current Understanding and Future Directions. | Clin Breast Cancer | 2023 |
| 36944408 | Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel. | J Mol Diagn | 2023 |
| 37443169 | Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity? | NPJ Breast Cancer | 2023 |
| 37277454 | Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. | Nat Med | 2023 |
| 37435097 | Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment. | Oncoimmunology | 2023 |
| 37269905 | ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. | Ann Oncol | 2023 |
| 37198249 | A framework for artificial intelligence in cancer research and precision oncology. | NPJ Precis Oncol | 2023 |
| 37195235 | A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer. | Clin Cancer Res | 2023 |
| 36520447 | Clinical Trials and Digital Pathology-Toward Quantitative Therapeutic Immunohistochemistry and Tissue Hybridization. | JAMA Oncol | 2023 |
| 36538386 | Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection. | Arch Pathol Lab Med | 2023 |
| 36804617 | Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype. | Gynecol Oncol | 2023 |
| 36828363 | NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift. | Mod Pathol | 2023 |
| 36494075 | Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers. | J Thorac Oncol | 2023 |
| 36929936 | Overcoming the challenges to implementation of artificial intelligence in pathology. | J Natl Cancer Inst | 2023 |
| 36593350 | Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. | NPJ Precis Oncol | 2023 |
| 36355783 | Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer. | Cancer Discov | 2023 |
| 36323507 | <i>KIT</i> genetic alterations in breast cancer. | J Clin Pathol | 2023 |
| 33148628 | Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites. | J Clin Pathol | 2022 |
| 35809752 | ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. | Ann Oncol | 2022 |
| 35444182 | Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers. | NPJ Breast Cancer | 2022 |
| 35411948 | Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix. | J Pathol | 2022 |
| 35440717 | Delivering precision oncology to patients with cancer. | Nat Med | 2022 |
| 35764743 | Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. | Nat Cancer | 2022 |
| 35699480 | Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma. | J Natl Cancer Inst | 2022 |
| 35418131 | LINC00355 regulates p27<sup>KIP</sup> expression by binding to MENIN to induce proliferation in late-stage relapse breast cancer. | NPJ Breast Cancer | 2022 |
| 35849120 | Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles. | Clin Cancer Res | 2022 |
| 36551247 | Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer. | Biomolecules | 2022 |
| 35971132 | Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. | Genome Med | 2022 |
| 35999225 | ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance. | NPJ Breast Cancer | 2022 |
| 36357680 | Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. | Nat Med | 2022 |
| 35953528 | Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy. | NPJ Breast Cancer | 2022 |
| 36289342 | Single-cell genomic variation induced by mutational processes in cancer. | Nature | 2022 |